Additional information
White Powder
334981-35-0
ACI-015214
N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine
N-methyl-2-5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-ylethanamine
227.3-228.9°C
C18H25N3O6S
411.47
Ambient
2-8°C
1H-Indole-3-ethanamine, N-methyl-5-[(1-pyrrolidinylsulfonyl)methyl]-, ethanedioate
Neurological disorder
Pharmaceutical Impurity Standards





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)